Excess of O-linked N-acetylglucosamine modifies human pluripotent stem cell differentiation

Stem Cell Research

Volumn 11, Issue 2, 2013, Pages 926-937

  Maury, Julien Jean Pierre ^a,b   Chan, Ken Kwok Keung ^c   Zheng, Lu ^a   Bardor, Muriel ^a,d   Choo, Andre Boon Hwa ^a,b  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITÉ DE ROUEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROLASE; N ACETYLGLUCOSAMINE; O LINKED N ACETYLGLUCOSAMINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR PAX6; TRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; ECTODERM; EMBRYO; EMBRYONIC STEM CELL; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MESODERM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION; UPREGULATION;

ACETYLGLUCOSAMINE; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; HYDROLASES; N-ACETYLGLUCOSAMINYLTRANSFERASES; PLURIPOTENT STEM CELLS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84880418751     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.06.004     Document Type: Article

References (59)

1. Adams J. Activation loop phosphorylation and catalysis in protein kinases: is there functional evidence for the autoinhibitor model?. Biochemistry 2003, 42(3):601-607.
2. Aurich H., Sgodda M., Kaltwasser P., Chirst B. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 2009, 58(4):570-581.
3. Bak X., Lam D., Yang J., Wang S. Human embryonic stem cell-derived mesenchymal stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma. Hum. Gene Ther. 2011, 22(11):1365-1377.
4. Bardy J., Chen A.K., Lim Y.M., Wu S., Wei S., Weiping H., Oh S.K.W. Microcarrier suspension cultures for high-density expansion and differentiation of human pluripotent stem cells to neural progenitor cells. Tissue Eng. Part C Methods 2013, 19(2):166-180.
5. Bratt-Leal A., Carpenedo R., McDevitt T. Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation. Biotechnol. Prog. 2009, 25(1):43-51.
6. Chang W., Lim S., Song B.-W., Lee C.Y., Park M.-S., Chung Y.-A., Hwang K.-C. Phorbol myristate acetate differentiates human adipose-derived mesenchymal stem cells into functional cardiogenic cells. Biochem. Biophys. Res. Commun. 2012, 424(4):740-746.
7. Cheray M., Petit D., Forestier L., Gallet F., Lalloue F. Glycosylation-related gene expression is linked to differentiation status in glioblastomas undifferentiated cells. Cancer Lett. 2011, 312(1):24-32.
8. Cheung W.D., Sakabe K., Housley M.P., Dias W.B., Hart G.W. O-linked beta-N-acetylglucosaminyltransferase substrate specificity is regulated by myosin phosphatase targeting and other interacting proteins. J. Biol. Chem. 2008, 283(49):33935-33941.
9. Choo A., Padmanabhan J., Chin A., Fong W., Oh S. Immortalized feeders for the scale-up of human embryonic stem cells in feeder and feeder-free conditions. J. Biotechnol. 2006, 122(1):130-141.
10. Chou C.-F., Smith A., Omary B. Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18. J. Biol. Chem. 1992, 267(6):3901-3906.
11. Chou T., Hart G. O-linked N-acetylglucosamine and cancer: messages from the glycosylation of c-Myc. Adv. Exp. Med. Biol. 2001, 491:413-418.
12. Comer F., Vosseller K., Wells L., Accavitti M., Hart G. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal. Biochem. 2001, 293(2):169-177.
13. Cressey D. Nature news. Stem cells take root in drug development Available at, (Accessed October 4, 2012). http://www.nature.com.ejproxy.a-star.edu.sg/news/stem-cells-take-root-in-drug-development-1.10713.
14. Dehennaut V., Lefebvre T., Leroy Y., Vilain J.-P., Michalski J.-C., Bodart J.-F. Survey of O-GlcNAc level variations in Xenopus laevis from oogenesis to early development. Glycoconjug. J. 2008, 26(3):301-311. 10.1007/s10719-008-9166-0.
15. Dias W., Hart G. O-GlcNAc modification in diabetes and Alzheimer's disease. Mol. Biosyst. 2007, 3(11):766-772.
16. Dong D., Hart G. Purification and characterization of an O-GlcNAc selective N-Acetyl-b-d-glucosaminidase from rat spleen cytosol. J. Biol. Chem. 1994, 269(30):19321-19330.
17. Douglas G., VandeVorrt C., Kumar P., Golos T. Trophoblast stem cells: models for investigating trophectoderm differentiation and placental development. Endocr. Rev. 2009, 30(3):228-240.
18. Fong J., Ngyuyen B., Bridger R., Sifers R. β-N-acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3. J. Biol. Chem. 2012, 287(15):12195-12203.
19. Francisco H., Kollins K., Gallo G. O-GLcNAc post-translational modifications regulate the entry of neurons into an axon branching program. Dev. Neurobiol. 2009, 69(2-3):162-173.
20. Ginis I., Luo Y., Miura T., Thies S., Brandenberger R., Gerecht-Nir S. Differences between human and mouse embryonic stem cells. Dev. Biol. 2004, 269(2):360-380.
21. Grabel L. Prospects for pluripotent stem cell therapies: into the clinic and back to the bench. J. Cell. Biochem. 2012, 113(2):381-387.
22. Greber B., Wu G., Bernemann C., Joo J.Y., Han D.W., Ko K., Schöler H.R. Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cell Stem Cell 2010, 6(3):215-226.
23. Haltiwanger R.S., Grove K., Philipsberg G.A. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-dglucopyranosylidene) amino-N-phenylcarbamate. J. Biol. Chem. 1998, 273(6):3611.
24. Haltiwanger Robert S., Blomberg M.A., Hart G.W. Glycosylation of nuclear and cytoplasmic proteins. J. Biol. Chem. 1992, 267(13):9005-9013.
25. Hart G., Akimoto Y. Essentials of Glycobiology 2009, Cold Spring Harbor Laboratory Press. 2nd edition.
26. Hematti P. Human embryonic stem cell-derived mesenchymal progenitors: an overview. Methods Mol. Biol. 2011, 690:163-174.
27. Ishihara K., Takahashi I., Tsuchiya Y., Hasegawa M., Kamemura K. Characteristic increase in nucleocytoplasmic protein glycosylation by O-GlcNAc in 3T3-L1 adipocyte differentiation. Biochem. Biophys. Res. Commun. 2010, 398(3):489-494.
28. Issad T., Kuo M.S. O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity. Trends Endocrinol. Metab. 2008, 19(10):380-389.
29. Issad T., Masson E., Pagesy P. O-GlcNAc modification, insulin signaling and diabetic complications. Diabetes Metab. 2010, 36:423-425.
30. Itskovitz-Eldor J., Schuldiner M., Karsenti D., Eden A., Yanuka O., Amit M. Differentiation of human embryonic stem cells into embryoid bodies comprising the three embryonic germ layers. Mol. Med. 2000, 6(2):88-95.
31. Jang H., Kim T.W., Yoon S., Choi S.-Y., Kang T.-W., Kim S.-Y., Youn H.-D. O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell 2012, 11(1):62-74.
32. Ji S., Park S.Y., Roth J., Kim H.S., Cho J.W. O-GlcNAc modification of PPARgamma reduces its transcriptional activity. Biochem. Biophys. Res. Commun. 2011, 417:1158-1163.
33. Jowsey I.R., Smith S.A., Hayes J.D. Expression of the murine glutathione S-transferase α3 (GSTA3) subunit is markedly induced during adipocyte differentiation: activation of the GSTA3 gene promoter by the pro-adipogenic eicosanoid 15-deoxy-δ12,14-prostaglandin J2. Biochem. Biophys. Res. Commun. 2003, 312(4):1226-1235.
34. Karlssson C., Emanuelsson K., Wessberg F., Strehl R. Human embryonic stem cell-derived mesenchymal progenitors-potential in regenerative medicine. Stem Cell Res. 2009, 3(1):39-50.
35. Kawakami Y., Yoshida K., Yang J.H., Suzuki T., Azuma N., Sakai K., Furuya S. Impaired neurogenesis in embryonic spinal cord of Phgdh knockout mice, a serine deficiency disorder model. Neurosci. Res. 2009, 63(3):184-193.
36. Kim H., Kim E., Kim Y., Choo J. Heat shock protein 60 modified with O-linked N-acetylglucosamine is involved in pancreatic b-cell death under hyperglycemic conditions. FEBS Lett. 2006, 580:2311-2316.
37. Kim H.S., Park S.Y., Choi Y.R., Kang J.G., Joo H.J., Moon W.K., Cho J.W. Excessive O-GlcNAcylation of proteins suppresses spontaneous cardiogenesis in ES cells. FEBS Lett. 2009, 583(15):2474-2478.
38. Li X., Monila H., Tang Q. O-linked N-acetylglucosamine modification on CCAAT enhancer-binding protein beta: role during adipocyte differentiation. J. Biol. Chem. 2009, 17(284):19248-19254.
39. Macauley M.S., Vocadlo D.J. Increasing O-GlcNAc levels: an overview of small-molecule inhibitors of O-GlcNAcase. Biochim. Biophys. Acta 2010, 1800(2):107-121.
40. Matsuda N., Mishina M. Identification of chaperonin CCT gamma subunit as a determinant of retinotectal development by whole-genome subtraction cloning from zebrafish no tectal neuron mutant. Development 2004, 131(9):1913-1925.
41. Mihaila S., Frias A., Pirraco R., Marques A. Human adipose tissue-derived SSEA-4 sub-population multi-differentiation potential towards the endothelial and osteogenic lineages. Tissue Eng. Part A 2012, 19(1-2):235-246.
42. Odorico J., Kaufman D., Thomson J. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 2001, 19:193-204.
43. Park S.Y., Ryu J., Lee W. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes. Exp. Mol. Med. 2005, 37(3):220-229.
44. Roskoski R. Src kinase regulation by phosphorylation and dephosphorylation. Biochem. Biophys. Res. Commun. 2005, 331(1):1-14.
45. Schnerch A., Cerdan C., Bhatia M. Distinguishing between mouse and human pluripotent stem cell regulation: the best laid plans of mice and men. Stem Cells 2010, 28(3):419-430.
46. Shafi R., Iyer S.P., Ellies L.G., O'Donnell N., Marek K.W., Chui D., Marth J.D. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(11):5735.
47. Silva A.C., Percegona L.S., França A.L., dos Santos T.M., Perini C.C., González P., Aita C.A.M. Expression of pancreatic endocrine markers by mesenchymal stem cells from human adipose tissue. Transplant. Proc. 2012, 44(8):2495-2496.
48. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
49. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282(5391):1145-1147.
50. Torres C.R., Hart G.W. Topography and polypeptide distribution of terminal n-acetylglucosamine residues on the surfaces of intact lymphocytes. J. Biol. Chem. 1984, 259(5):3308-3317.
51. Van Hoof D., Passier R., Oostwaard D., Mummery C., Krijgsveld J. A quest for human and mouse embryonic stem cell-specific proteins. Mol. Cell. Proteomics 2006, 5:1261-1273.
52. Van Hoof Dennis, Muñoz J., Braam S.R., Pinkse M.W.H., Linding R., Heck A.J.R., Krijgsveld J. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 2009, 5(2):214-226.
53. Webster D.M., Teo C.F., Sun Y., Wloga D., Gay S., Klonowski K.D., Dougan S.T. O-GlcNAc modifications regulate cell survival and epiboly during zebrafish development. BMC Dev. Biol. 2009, 9(1):28.
54. Wu S., Tan K.S., Choo A., Chan K. Enhanced production of neuroprogenitors, dopaminergic neurons and identification of target genes by overexpression of sonic hedgehog in human embryonic stem cells. Stem Cells Dev. 2012, 21(5):729-741.
55. Yagi H., Saito T., Yanagisawa M., Yu R., Kato K. Lewis X-carrying N-glycans regulate the proliferation of mouse embryonic neural stem cells via the Notch signaling pathway. J. Biol. Chem. 2012, 287(29):24356-24364.
56. Yanagisawa M., Yu R.K. O-linked-N-acetylglucosaminylation in mouse embryonic neural precursor cells. J. Neurosci. Res. 2009, 87(16):3535-3545.
57. Yuzwa S.A., Macauley M.S., Heinonen J.E., Shan X., Dennis R.J., He Y., Vocadlo D.J. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat. Chem. Biol. 2008, 4(8):483-490.
58. Zachara N., Hart G. Cell signaling, the essential role of O-GlcNAc!. Biochim. Biophys. Acta 2006, 1761(5-6):599-617.
59. Zachara N., Vosseller K., Hart G. Detection and analysis of proteins modified by o-linked N-acetylglucosamine. Curr. Protoc. Protein Sci. 2011, 12.